|
1
|
Spritz RA: The genetics of vitiligo. J
Invest Dermatol. 131(E1): E18–E20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Birlea SA, Jin Y, Bennett DC, Herbstman
DM, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP,
Picardo M, et al: Comprehensive association analysis of candidate
genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J
Invest Dermatol. 131:371–381. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Quan C, Ren YQ, Xiang LH, Sun LD, Xu AE,
Gao XH, Chen HD, Pu XM, Wu RN, Liang CZ, et al: Genome-wide
association study for vitiligo identifies susceptibility loci at
6q27 and the MHC. Nat Genet. 42:614–618. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rahoma SF, Sandhu HK, McDonagh AJ,
Gawkrodger DJ, Weetman AP and Kemp EH: Epitopes, avidity and IgG
subclasses of tyrosine hydroxylase autoantibodies in vitiligo and
alopecia areata patients. Br J Dermatol. 167:17–28. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park YK, Kim NS, Hann SK and Im S:
Identification of autoantibody to melanocytes and characterization
of vitiligo antigen in vitiligo patients. J Dermatol Sci.
11:111–120. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li S, Yao W, Pan Q, Tang X, Zhao S, Wang
W, Zhu Z, Gao J, Sheng Y, Zhou F, et al: Association analysis
revealed one susceptibility locus for vitiligo with immune-related
diseases in the Chinese Han population. Immunogenetics. 67:347–354.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Evoli A, Caliandro P, Iorio R, Alboini PE,
Damato V, LaTorre G, Provenzano C, Marino M, Lauriola L, Scuderi F,
et al: Poly-autoimmunity in patients with myasthenia gravis: A
single-center experience. Autoimmunity. 48:412–417. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Byrne KT, Zhang P, Steinberg SM and Turk
MJ: Autoimmune vitiligo does not require the ongoing priming of
naive CD8 T cells for disease progression or associated protection
against melanoma. J Immunol. 192:1433–1439. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Colucci R, Böhm M and Moretti S:
Commentary from the Editorial Board to Vitiligo: Interplay between
oxidative stress and immune system (Laddha et al). Exp
Dermatol. 22:397–398. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ingordo V, Cazzaniga S, Raone B,
Digiuseppe MD, Musumeci ML, Fai D, Pellegrino M, Pezzarossa E, Di
Lernia V, Battarra VC, et al: Circulating autoantibodies and
autoimmune comorbidities in vitiligo patients: a multicenter
Italian study. Dermatology. 228:240–249. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gregg RK, Nichols L, Chen Y, Lu B and
Engelhard VH: Mechanisms of spatial and temporal development of
autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J
Immunol. 184:1909–1917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alkhateeb A, Fain PR, Thody A, Bennett DC
and Spritz RA: Epidemiology of vitiligo and associated autoimmune
diseases in Caucasian probands and their families. Pigment Cell
Res. 16:208–214. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Petersen M, Davids LM and Kidson SH:
Simultaneous immunofluorescent labeling using anti-BrdU monoclonal
antibody and a melanocyte-specific marker in formalin-fixed
paraffin-embedded human skin samples. Appl Immunohistochem Mol
Morphol. 20:614–617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Okamoto T, Irie RF, Fujii S, Huang SK,
Nizze AJ, Morton DL and Hoon DS: Anti-tyrosinase-related protein-2
immune response in vitiligo patients and melanoma patients
receiving active-specific immunotherapy. J Invest Dermatol.
111:1034–1039. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aletaha D, Neogi T, Silman AJ, Funovits J,
Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP,
Cohen MD, et al: 2010 Rheumatoid arthritis classification criteria:
an American College of Rheumatology/European League Against
Rheumatism collaborative initiative. Arthritis Rheum. 62:2569–2581.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hochberg MC: Updating the American College
of Rheumatology revised criteria for the classification of systemic
lupus erythematosus. Arthritis Rheum. 40:17251997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ezzedine K, Lim HW, Suzuki T, Katayama I,
Hamzavi I, Lan CC, Goh BK, Anbar T, de Silva Castro C, Lee AY, et
al: Vitiligo Global Issue Consensus Conference Panelists: Revised
classification/nomenclature of vitiligo and related issues: The
Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma
Res. 25:E1–E13. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rubio-Tapia A, Hill ID, Kelly CP,
Calderwood AH and Murray JA: American College of Gastroenterology:
ACG clinical guidelines: diagnosis and management of celiac
disease. Am J Gastroenterol. 108:656–676; quiz 677. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garber JR, Cobin RH, Gharib H, Hennessey
JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA and Woeber
KA: American Association of Clinical Endocrinologists and American
Thyroid Association Taskforce on Hypothyroidism in Adults: Clinical
practice guidelines for hypothyroidism in adults: cosponsored by
the American Association of Clinical Endocrinologists and the
American Thyroid Association. Endocr Pract. 18:988–1028. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goudie RB, Spence JC and MacKie R:
Vitiligo patterns simulating autoimmune and rheumatic diseases.
Lancet. 2:393–395. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Santana C, Noris G, Meraz-Ríos MA, Magaña
JJ, Calderon-Aranda ES, Muñoz ML and Gómez R: Genetic analysis of
17 Y-STRs in a Mestizo population from the Central Valley of
Mexico. Hum Biol. 86:289–312. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ruiz-Maldonado R, Tamayo Sánchez L and
Velázquez E: Epidemiology of skin diseases in 10,000 patients of
pediatric age. Bol Med Hosp Infant Mex. 34:137–161. 1977.(In
Spanish). PubMed/NCBI
|
|
23
|
Krüger C and Schallreuter KU: A review of
the worldwide prevalence of vitiligo in children/adolescents and
adults. Int J Dermatol. 51:1206–1212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee H, Lee MH, Lee DY, Kang HY, Kim KH,
Choi GS, Shin J, Lee HJ, Kim DH, Kim TH, et al: Prevalence of
vitiligo and associated comorbidities in Korea. Yonsei Med J.
56:719–725. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu T, Gao T, Wang A, Jin Y, Li Q and Li C:
Vitiligo prevalence study in Shaanxi Province, China. Int J
Dermatol. 46:47–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Humbert P and Dupond JL: Multiple
autoimmune syndromes. Ann Med Interne (Paris). 139:159–168.
1988.(In French). PubMed/NCBI
|
|
27
|
Anaya JM: The diagnosis and clinical
significance of polyautoimmunity. Autoimmun Rev. 13:423–426. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Anaya JM, Castiblanco J, Rojas-Villarraga
A, Pineda-Tamayo R, Levy RA, Gómez-Puerta J, Dias C, Mantilla RD,
Gallo JE, Cervera R, et al: The multiple autoimmune syndromes. A
clue for the autoimmune tautology. Clin Rev Allergy Immunol.
43:256–264. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rojas-Villarraga A, Amaya-Amaya J,
Rodriguez-Rodriguez A, Mantilla RD and Anaya JM: Introducing
polyautoimmunity: secondary autoimmune diseases no longer exist.
Autoimmune Dis. 2012:2543192012.PubMed/NCBI
|
|
30
|
Cojocaru M, Cojocaru IM and Silosi I:
Multiple autoimmune syndrome. Maedica (Buchar). 5:132–134.
2010.PubMed/NCBI
|
|
31
|
Liu JB, Li M, Yang S, Gui JP, Wang HY, Du
WH, Zhao XY, Ren YQ, Zhu YG and Zhang XJ: Clinical profiles of
vitiligo in China: An analysis of 3742 patients. Clin Exp Dermatol.
30:327–331. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Z, Xu SX, Zhang FY, Yin XY, Yang S,
Xiao FL, Du WH, Wang JF, Lv YM, Tang HY, et al: The analysis of
genetics and associated autoimmune diseases in Chinese vitiligo
patients. Arch Dermatol Res. 301:167–173. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Laberge G, Mailloux CM, Gowan K, Holland
P, Bennett DC, Fain PR and Spritz RA: Early disease onset and
increased risk of other autoimmune diseases in familial generalized
vitiligo. Pigment Cell Res. 18:300–305. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee YH and Bae SC: Associations between
TNF-α polymorphisms and susceptibility to rheumatoid arthritis and
vitiligo: A meta-analysis. Genet Mol Res. 14:5548–5559. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Roguedas AM, Misery L, Sassolas B, Le
Masson G, Pennec YL and Youinou P: Cutaneous manifestations of
primary Sjögren's syndrome are underestimated. Clin Exp Rheumatol.
22:632–636. 2004.PubMed/NCBI
|
|
36
|
Abraham Z, Rozenbaum M, Glück Z, Feuerman
EJ, Lahat N and Kinarty A: Vitiligo, rheumatoid arthritis and
pernicious anemia. J Dermatol. 20:418–423. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chan HL, Lee YS, Hong HS and Kuo TT:
Anticentromere antibodies (ACA): Clinical distribution and disease
specificity. Clin Exp Dermatol. 19:298–302. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ponto KA, Schuppan D, Zwiener I, Binder H,
Mirshahi A, Diana T, Pitz S, Pfeiffer N and Kahaly GJ:
Thyroid-associated orbitopathy is linked to gastrointestinal
autoimmunity. Clin Exp Immunol. 178:57–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Boelaert K, Newby PR, Simmonds MJ, Holder
RL, Carr-Smith JD, Heward JM, Manji N, Allahabadia A, Armitage M,
Chatterjee KV, et al: Prevalence and relative risk of other
autoimmune diseases in subjects with autoimmune thyroid disease. Am
J Med. 123:183.e1–183.e9. 2010. View Article : Google Scholar
|
|
40
|
Amador-Patarroyo MJ, Arbelaez JG, Mantilla
RD, Rodriguez-Rodriguez A, Cárdenas-Roldán J, Pineda-Tamayo R,
Guarin MR, Kleine LL, Rojas-Villarraga A and Anaya JM: Sjögren's
syndrome at the crossroad of polyautoimmunity. J Autoimmun.
39:199–205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Larizza D, Calcaterra V, Klersy C, Badulli
C, Caramagna C, Ricci A, Brambilla P, Salvaneschi L and Martinetti
M: Common immunogenetic profile in children with multiple
autoimmune diseases: the signature of HLA-DQ pleiotropic genes.
Autoimmunity. 45:470–475. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zakka LR, Reche PA and Ahmed AR: The
molecular basis for the presence of two autoimmune diseases
occurring simultaneously - preliminary observations based on
computer analysis. Autoimmunity. 45:253–263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zheng J, Ibrahim S, Petersen F and Yu X:
Meta-analysis reveals an association of PTPN22 C1858T with
autoimmune diseases, which depends on the localization of the
affected tissue. Genes Immun. 13:641–652. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cárdenas-Roldán J, Rojas-Villarraga A and
Anaya JM: How do autoimmune diseases cluster in families? A
systematic review and meta-analysis. BMC Med. 11:732013. View Article : Google Scholar : PubMed/NCBI
|
